Joint symposium with the ISHLT: End-stage PAH - how and what do we do in 2021?
A PVRI 2024 Digital webinar
Presentations
- When should a PH patient be considered for lung transplant? John Granton
- Atrial septum defect creation or mechanical support for end-stage PAH Erika Rosenzweig
- Lung and Heart-lung Transplant in 2021 – how well do PAH patients do? Eugene Golts
- Pluripotent stem cell-based approaches and the future of artificial lungs Ulrich Martin
- Timing and extent of ventricular reverse remodelling after lung transplant for PH Ryan Tedford
Polls
Start of webinar poll (18 responses)
1. Talk 1: Improving survival AND quality of life are equally important considerations when considering timing of transplantation for PAH.
Agree - 100%
Disagree - 0%
2. Talk 2: Atrial septostomy can be used as a palliative bridge for end-stage PAH?
Agree - 66.67%
Disagree - 33.33%
3. Talk 3: the timing of referral for the Lung Transplantation for Pulmonary Hypertension should be solely determined based on available risk calculators?
Yes - 27.78%
No - 72.22%
4. Talk 4: Treatment of pulmonary arterial hypertension via iPS-based cellular therapies will become reality during the next 15 years
Yes - 72.22%
No - 27.78%
5. Talk 5: Patients with end-stage PAH and very severe RV dysfunction should be considered for heart-lung transplant rather than isolated (bilateral) lung
Yes - 66.67%
No - 33.33%
End of webinar poll (6 responses)
1. Talk 1: Improving survival AND quality of life are equally important considerations when considering timing of transplantation for PAH.
Agree - 100%
Disagree - 0%
2. Talk 2: Atrial septostomy can be used as a palliative bridge for end-stage PAH?
Agree - 100%
Disagree - 0%
3. Talk 3: the timing of referral for the Lung Transplantation for Pulmonary Hypertension should be solely determined based on available risk calculators?
Yes - 33.33%
No - 66.67%
4. Talk 4: Treatment of pulmonary arterial hypertension via iPS-based cellular therapies will become reality during the next 15 years
Yes - 33.33%
No - 66.67%
5. Talk 5: Patients with end-stage PAH and very severe RV dysfunction should be considered for heart-lung transplant rather than isolated (bilateral) lung
Yes - 50%
No - 50%